T cells;
cytokine-induced killer cells;
immunotherapy;
D O I:
10.1007/s002770050257
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.
机构:
Peking University 302 Clinical Medical SchoolPeking University 302 Clinical Medical School
Tian-Tian Li
Jing Sun
论文数: 0引用数: 0
h-index: 0
机构:
Radiation Oncology Department, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School
Jing Sun
Quan Wang
论文数: 0引用数: 0
h-index: 0
机构:
Radiation Oncology Department, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School
Quan Wang
Wen-Gang Li
论文数: 0引用数: 0
h-index: 0
机构:
Radiation Oncology Department, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School
Wen-Gang Li
Wei-Ping He
论文数: 0引用数: 0
h-index: 0
机构:
Radiation Oncology Department, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School
Wei-Ping He
Rui-Chuang Yang
论文数: 0引用数: 0
h-index: 0
机构:
Research Center for Clinical & Translational Medicine, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School
Rui-Chuang Yang
Xue-Zhang Duan
论文数: 0引用数: 0
h-index: 0
机构:
Peking University 302 Clinical Medical School
Radiation Oncology Department, the Fifth Medical Center of Chinese PLA General HospitalPeking University 302 Clinical Medical School